ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000009370
Date of registration:	21/11/2012
Prospective Registration:	Yes
Primary sponsor:	National Center for Child Heath and Development
Public title:	Thalidomide therapy clinical trial for chronic granulomatous disease-associated intractable granulomatous lesion
Scientific title:	Thalidomide therapy clinical trial for chronic granulomatous disease-associated intractable granulomatous lesion - Thalidomide therapy for chronic granulomatous disease
Date of first enrolment:	2012/12/07
Target sample size:	5
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011015
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Toshinao Kawai
Address:	2-10-1 Okura, Setagaya-ku, Tokyo, Japan Japan
Telephone:	03-3416-0181
Email:	kawai-t@ncchd.go.jp
Affiliation:	National Center for Child Heath and Development Department of Human Genetics

Name:	TOSHINAO KAWAI
Address:	2-10-1 Okura, Setagaya-ku, Tokyo, Japan Japan
Telephone:	03-3416-0181
Email:	kawai-t@ncchd.go.jp
Affiliation:	National Center for Child Heath and Development Department of Human Genetics

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: a pregnant woman positive for HIV severe allegy

Age minimum: 3years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Chronic granulomatous disease

Intervention(s)

Oral administration of thalidomide

Primary Outcome(s)

Cure or mitigation of granulomatous lesion

Secondary Outcome(s)

An effect on susceptibility to infection

Secondary ID(s)

Source(s) of Monetary Support

Grant of MHLW

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:	Yes
Date Posted:
Date Completed:	30/04/2017
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.